The global demand for Deuterated Drugs Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
A deuterated drug refers to a small drug molecule in which hydrogen atom/atoms in the drug molecules are replaced by its stable and heavier isotope deuterium. Deuteration affects the pharmacokinetic properties of the drug, such as metabolism. Deuteration lowers the metabolism of drugs, increases chemical bond strength, and improves the stability, safety, and tolerability of the drug. Deuterated drugs have a longer half-life, enhanced efficacy, and lower toxicity. Deuterated drugs are used to treat diseases such as chorea (an involuntary movement disorder) associated with Huntington’s disease and tardive dyskinesia and cancer. The FDA has granted marketing to the First deuterated drug molecule, deutetrabenazine, which is an analog of the old drug tetrabenazine. Deutetrabenazine is used to treat chorea.
The market demand for deuterated drugs is rising due to their unique properties such as higher efficacy and longer half-life. Besides, factors such as the increasing prevalence of rare diseases such as Huntington’s disease and growing demand for lower toxic drugs is further driving the market. Furthermore, increasing FDA grants for a deuterated drug and rising government initiatives to set up guidelines are other reasons leading to the growth of deuterated drug market.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of deuterated drugs. The growth and trends of deuterated drugs industry provide a holistic approach to this study.
This section of the deuterated drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
- Huntington'S Disease (HD)
- Tardive Dyskinesia (TD)
This section covers the regional outlook, which accentuates current and future demand for the Deuterated Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Deuterated Drugs Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the deuterated drugs market include Teva, Suzhou Zelgen Biopharmaceuticals, Concert Pharmaceuticals, Vertex Pharmaceuticals, Hinova Pharma, Otsuka Pharmaceutical (Avanir), Poxel SA (DeuteRx). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.